#TSP TruSpine Technologies PLC – Subscription, RPT, Issue of Equity May 23, 2025 – Posted in: TruSpine Plc (TSP)

Director/PDMR Shareholding TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that the Company has entered into a subscription agreement with Axis MedTech (Holdings) Limited (“Axis”), for Axis to subscribe for 3,300,000 new ordinary shares of 0.01 pence in the Company (“Ordinary Shares”) at a price of 1.5 pence per share (“Subscription Shares”), raising gross proceeds of £49,500 (“Subscription”). In addition, Geoff Miller has disposed of his £136,573…

#VELA investee co. #ENSI EnSilica PLC – New Debt Facility November 4, 2024 – Posted in: Uncategorized

EnSilica, a leading chip maker of mixed signal ASICs (Application Specific Integrated Circuits), is pleased to announce that it has secured a new debt facility to refinance its existing external loan facilities, providing total funding of up to £9 million and extending out to November 2029 (the “Facility”). The Facility has been agreed with Lloyds Bank Group plc, providing the Company with additional flexibility to underpin ongoing working capital commitments, and ensuring that EnSilica…

#VELA Vela Technologies PLC – Investment in Igraine plc via CLN October 21, 2024 – Posted in: Vela Technologies Plc (VELA)

The Board of Vela (AIM:VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, announces that on 18 October 2024 it entered into a conditional unsecured convertible loan note agreement (“the Agreement”) with Igraine plc (“Igraine”), an investment company focused on opportunities in breakthrough technologies and life sciences (AQSE:KING). Vela currently holds 23,928,080 ordinary shares in Igraine representing 27.66 per cent. of Igraine’s current issued share capital, Vela having acquired the equity…

#TSP TruSpine Technologies PLC – Convertible Loan Note Extension & RPT July 24, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, that further to the announcement on 28 March 2024, the Company has extended the maturity date of the convertible loan note (“CLN”) to 30 June 2025. All other terms of the CLN remain unchanged. Related Party Transaction The extension of maturity date of the CLN (the “Transaction”) is a related party transaction for the purposes of Rule 4.6 of the AQSE…

#VELA investee co. #TRYB Tribe Technologies PLC – £1.41 million Fundraise June 26, 2024 – Posted in: Uncategorized

Tribe Technology PLC (AIM: TRYB), a disruptive technology-first developer and manufacturer of world-class autonomous mining equipment, announces that it has conditionally raised, in aggregate, gross proceeds of approximately £1.41 million through (i) a placing (the “Placing“) of 14,216,652 new ordinary shares (the “Placing Shares“) of 0.05 pence each in the share capital of the Company (“Ordinary Shares“) to new and existing institutional investors (“Placees“) at an issue price of 4.50 pence per new Ordinary Share…

#TSP TruSpine Technologies PLC – AGM Statement & Loans Update March 15, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, is pleased to announce that at the Company’s 2022 Annual General Meeting (“AGM”) to be held later today. The Chairman Geoff Miller will make the following statement: “As your newly appointed Chairman, I am pleased to report the Board intends to:- · Raise further capital for the Company, thus further strengthening the Company’s financial position; · Review corporate governance procedures at…

#TSP Truspine Technologies PLC – Convertible Loan, Loan Update, AGM Update and RPT February 14, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has entered into a £50,000 convertible loan note agreement with Martin Armstrong (the “CLN Agreement”), the former Non-Executive Chairman of the Company. The Company also provides an update on the loan agreement announced on 5 January 2024 and on its 2022 annual general meeting (“2022 AGM”) which is due to be convened. CLN Agreement Pursuant to the…

#TSP Truspine Technologies PLC – Loan, Related Party Transaction and FDA Update January 5, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has entered into a £30,000 loan agreement with Annabel Schild (the “Loan Agreement”), a former Non-Executive Director of the Company within 12 months of the Loan Agreement being entered into and therefore is considered a related party pursuant to the AQSE Growth Market Access Rulebook. The Company also provides an update on its U.S. Food and Drug Administration…

#VELA investee co. #TRYB Tribe Technology PLC – Term Facility secured with Beach Point Capital October 25, 2023 – Posted in: Blog, Vela Technologies Plc (VELA)

Tribe Technology PLC (AIM: TRYB), a disruptive developer and manufacturer of autonomous mining equipment, is pleased to announce that it has entered into a £3.0 million secured term loan facility agreement with BPC UK Lending DAC (the “Lender” or “Beach Point Capital”) (together the “Facility”). Highlights · Injection of £3.0 million into the business to principally refinance the Company’s legacy debt arrangements and further progress its previously outlined execution strategy. · Following drawdown…

TruSpine Technologies #TRU – Loan repayment & Update June 28, 2023 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that, further to the announcement on 25 April 2023, the Company has repaid the £100,000 loan and accrued interest under the Loan Agreement with Annabel Schild. The Funding Loan was repaid from existing cash resources following receipt of a HMRC R&D tax credit of approximately £200,000 (“Tax Credit”). Update on Working Capital The Company has limited…